Journal article
Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain
- Abstract:
-
Fear of fatal respiratory depression is a major driver limiting opioid prescription for persistent breathlessness in chronic obstructive pulmonary disease (COPD) [1–6], but is this fear warranted? In a recent systematic review and meta-analysis, VERBERKT et al. [7] did not detect significant or clinically relevant respiratory adverse events associated with opioid treatment for chronic breathlessness in COPD. Rather, they concluded that “clinicians’ fears of respiratory obtundation with low-do...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Authors
Bibliographic Details
- Publisher:
- European Respiratory Society Publisher's website
- Journal:
- European Respiratory Journal Journal website
- Volume:
- 51
- Issue:
- 3
- Pages:
- 1702531
- Publication date:
- 2018-03-01
- Acceptance date:
- 2017-12-21
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
- Pmid:
-
29496786
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:828746
- UUID:
-
uuid:6a51ec3d-cd00-436a-a592-10e412150a87
- Local pid:
- pubs:828746
- Source identifiers:
-
828746
- Deposit date:
- 2018-06-08
Terms of use
- Copyright date:
- 2018
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record